✕
For Patients & Families
Our Science
About Us
Connect with Us
February 2022: AAAAI Annual Meeting
STAR-0215 Is a Long-Acting Monoclonal Antibody Plasma Kallikrein Inhibitor in Development for Treatment of HAE
Nov. 2021: ACAAI Annual Scientific Meeting
STAR-0215 Is a Long-Acting Monoclonal Antibody Plasma Kallikrein Inhibitor for the Potential Treatment of HAE
Oct. 2021: NORD Summit
Burdens of Disease and Treatment in Hereditary Angioedema: Interview Insights from HAE Patients
